variou
virus
impact
host
lipid
metabol
lipidmembran
transport
lipid
mediat
signal
transduct
key
class
lipid
involv
cellular
process
class
phosphoinositid
pi
phosphatidylinositol
ptdin
basic
scaffold
pi
fig
inositol
moieti
ptdin
revers
phosphoryl
three
five
free
hydroxylgroup
posit
differenti
phosphoryl
result
seven
differ
speci
pi
local
distinct
cellular
compart
togeth
protein
factor
defin
ident
ptdin
found
earli
late
endosom
golgi
complex
fig
sever
distinct
subcellular
locat
pi
p
pi
p
fig
pi
p
transient
locat
plasma
membran
pi
p
endosomelysosom
axi
besid
differenti
spatial
distribut
within
cell
pi
also
tightli
regul
time
spatial
tempor
regul
mediat
differ
pi
kinas
phosphatas
key
spatial
regul
pi
distinct
substrat
specif
differenti
intracellular
local
enzym
henc
specif
pi
speci
confin
similar
membran
compart
concomit
kinas
result
distinct
spatial
distribut
differ
pi
speci
cell
tempor
regul
pi
cell
ascertain
fast
catalyt
rate
pi
kinas
phosphatas
result
rapid
synthesi
turnov
pi
cellular
membran
pi
lipid
anchor
cytoplasmat
leaflet
membran
togeth
small
gtpase
pi
abl
recruit
specif
downstream
effector
protein
way
seven
pi
speci
directli
indirectli
modul
numer
cellular
event
process
help
defin
ident
cellular
organel
ii
mediat
signal
transduct
cell
surfac
iii
involv
regul
membran
permeabl
traffic
furthermor
pi
also
involv
iv
remodel
actin
cytoskeleton
v
dna
repair
transcript
regul
rna
dynam
nucleu
vi
process
aid
cell
migrat
addit
pi
also
take
part
vii
process
cellular
polar
viii
import
modul
sphingolipid
metabol
phosphoinositid
pi
phospholipid
mediat
signal
cascad
cell
bind
effector
protein
revers
phosphoryl
inositol
ring
posit
result
synthesi
seven
differ
phosphoinositid
phosphoinositid
uniqu
subcellular
distribut
predomin
local
subset
membran
lipid
play
major
role
recruit
regul
function
protein
membran
interfac
sever
bacteria
virus
modul
exploit
host
pi
metabol
ensur
effici
replic
surviv
focu
role
cellular
phosphatidylinositol
phosphatidylinositol
replic
cycl
variou
virus
well
document
phosphatidylinositol
iiib
ec
indispens
viral
rna
replic
sever
picornavirus
two
recruit
strategi
report
bind
modul
enhanc
recruit
ii
interact
recruit
also
demonstr
crucial
hepat
c
viru
hcv
replic
appear
directli
recruit
activ
hcv
protein
replic
complex
contrast
picornavirus
still
debat
whether
b
isoform
import
explor
target
inhibit
viral
replic
challeng
develop
highli
select
inhibitor
andor
b
avoid
offtarget
toxic
elsevi
inc
right
reserv
mani
pathogen
exploit
pi
har
cell
resourc
replic
mani
intracellular
bacteri
pathogen
modul
exploit
pi
ensur
effici
replic
surviv
differ
strategi
employ
interfer
host
pi
metabol
includ
product
pimetabol
enzym
directli
affect
pi
level
host
cell
ii
pibind
effector
protein
use
pi
membran
anchor
iii
protein
lipid
factor
recruit
activ
inactiv
host
cell
pi
metabol
enzym
modul
pi
level
pathogeninduc
intracellular
vesicl
caus
chang
organel
ident
process
call
ident
theft
also
virus
shown
hijack
host
pi
metabol
benefici
replic
surviv
review
focu
role
cellular
phosphatidylinositol
phosphatidylinositol
replic
number
virus
discuss
potenti
target
inhibit
viral
replic
number
synthet
path
lead
format
fig
either
ptdin
phosphoryl
phosphatidylinositol
dephosphoryl
pi
p
pi
p
phosphatas
current
four
isoform
identifi
mammal
subdivid
type
ii
type
iii
famili
base
size
catalyt
properti
enzym
famili
subdivid
ab
isoform
base
domain
structur
ie
type
ii
b
type
iii
b
type
ii
pi
enzym
ec
protein
abund
almost
cellular
membran
enrich
plasma
membran
prepar
palmitoyl
tether
enzym
membran
also
modul
catalyt
activ
moreov
catalyt
activ
type
ii
pi
control
mean
phosphoryl
date
function
type
ii
still
remain
somewhat
elus
main
contributor
cellular
level
probabl
role
posttransgolgi
network
traffick
endocyt
traffic
furthermor
recent
studi
suggest
take
part
regul
sphingolipid
homeostasi
lysosom
deliveri
bglucocerebrosidas
requir
activ
sphingomyelin
synthesi
oxysterol
bind
protein
role
cancer
aktactiv
apoptosi
also
demonstr
cytosol
protein
recruit
plasma
membran
endoplasm
reticulum
golgi
may
role
membran
traffic
type
iii
b
ec
directli
bound
membran
case
share
structur
similar
inhibit
rel
high
concentr
inhibitor
eg
wortmannin
appar
molecular
weight
kda
mainli
local
golgi
fig
also
detect
nucleu
secretori
granul
synapt
vesicl
recruit
golgi
facilit
small
gtpbind
protein
also
extend
contribut
recruit
golgi
mammalian
cell
remain
unknown
enzymat
activ
also
modul
phosphoryl
one
multipl
phosphoryl
site
exampl
phosphoryl
shown
import
golgi
recruit
phosphoryl
protein
kinas
pkd
shown
essenti
kinas
activ
abil
support
postgolgi
transport
necessari
golgi
recruit
besid
pkd
kinas
phosphoryl
prolin
direct
cyclindepend
protein
kinas
like
cyclic
monophosphatedepend
protein
kinas
protein
kinas
ag
ca
calmodulindepend
protein
kinas
casein
kinas
ii
cyclindepend
kinas
type
iii
alpha
resid
predominantli
er
mammalian
cell
fig
also
found
pericentriolar
area
golgi
nucleolu
mammalian
nervou
system
distribut
uniqu
membran
cluster
associ
variou
organel
multivesicular
bodi
mitochondria
er
function
role
er
mammalian
cell
still
understood
recent
shown
requir
recruit
golgi
membran
function
role
plasma
membran
mammalian
cell
better
understood
take
part
signal
complex
associ
ion
channel
moreov
may
support
in
p
ca
signal
cascad
respons
product
plasma
membran
pool
base
potenti
phosphoryl
site
campdepend
protein
kinas
pka
protein
kinas
c
casein
kinas
ii
protein
tyrosin
kinas
suggest
involv
regul
phosphoryl
key
pi
physiolog
function
inositol
head
group
protrud
cytosol
leaflet
cell
membran
henc
allow
interact
pi
kinas
phosphatas
also
numer
protein
contain
specif
pibind
domain
aid
tether
protein
membran
case
integr
membran
protein
pibind
induc
conform
chang
result
alloster
regul
protein
exist
myriad
pibind
protein
belong
kind
protein
categori
specif
protein
exampl
clathrin
adaptor
ie
adaptor
protein
complex
gammaearcontain
adpribosyl
factorbind
protein
gga
epsinr
ii
lipidtransf
protein
fourphosphateadaptor
protein
fapp
ceramid
transport
protein
cert
oxysterolbind
protein
osbp
iii
protein
modul
golgi
function
accord
cell
metabol
pi
affin
pibind
protein
howev
low
requir
interact
membraneprotein
membraneassoci
small
gtpase
rab
protein
famili
order
stabil
interact
exampl
gga
bind
addit
also
small
gtpase
dual
recognit
ensur
correct
recruit
protein
specif
tran
compart
golgi
complex
cellular
organel
membran
domain
similar
combinatori
recognit
mechan
exist
determin
uniqu
ident
review
involv
architectur
golgi
complex
function
ii
sort
cargo
tran
golgi
network
iii
consecut
transport
golgi
plasma
membran
furthermor
import
sphingomyelin
synthesi
de
novo
sphingolipid
synthesi
start
cytosol
leaflet
er
differ
ceramid
synthes
de
novo
final
golgi
network
end
newli
synthes
ceramid
transport
er
vesicl
protein
cert
hepat
c
viru
hcv
sole
member
hepaciviru
genu
within
flavivirida
famili
group
envelop
singlestrand
positivesens
rna
virus
worldwid
million
person
chronic
infect
high
risk
develop
liver
cirrhosi
cancer
hcv
repres
major
health
burden
sever
posit
rna
virus
flavivirus
picornavirus
drastic
remodel
intracellular
membran
gener
special
environ
rna
replic
hcv
remodel
replic
membran
seem
deriv
endoplasm
reticulum
er
refer
membran
web
format
membran
web
induc
hcv
protein
addit
host
factor
shown
indispens
integr
membran
web
essenti
hcv
host
factor
identifi
across
numer
studi
phosphatidylinositol
tabl
fig
requir
kinas
activ
effici
hcv
replic
first
observ
sever
independ
sirnabas
screen
despit
differ
experiment
setup
differ
genotyp
replicon
vs
infecti
viru
analysi
later
studi
confirm
indispens
hcv
replic
particular
structur
integr
membran
hcv
replic
complex
silenc
express
led
format
abnorm
cluster
activ
recruit
hcv
hcv
replic
complex
interact
occur
domain
amino
acid
recent
requir
amino
acid
interact
assign
ctermin
end
domain
enzymat
activ
lipid
kinas
requir
hcv
replic
shown
rescu
experi
knockdown
cell
line
wildtyp
kinasedead
mutant
enzym
interestingli
kinas
activ
also
shown
enhanc
interact
level
membran
hcv
replic
complex
induc
massiv
accumul
lipid
confirm
infect
liver
tissu
obtain
hcvinfect
patient
present
howev
conflict
report
exist
specif
isoform
ab
requir
hcv
replic
public
design
essenti
isoform
hcv
tabl
howev
sirna
screen
also
emerg
indispens
host
factor
hcv
replic
depend
seem
associ
hcv
genotyp
nonetheless
recent
report
indic
role
hcv
genotyp
well
question
remain
essenti
isoform
hcv
replic
tai
colleagu
demonstr
shrna
inhibit
replic
dosedepend
manner
caus
alter
membran
web
morpholog
therefor
conclud
enrich
membran
web
due
activ
requir
contrast
anoth
recent
studi
found
essenti
hcv
replic
moreov
vesicular
transport
protein
coloc
requir
hcv
replic
shown
sirna
knockdown
experi
interestingli
transport
protein
also
indispens
enteroviru
replic
cf
infra
studi
obvious
requir
elucid
matter
reason
hcv
hijack
replic
remain
clarifi
one
hypothesi
hcv
recruit
gener
microenviron
lipid
replic
tabl
overview
publish
studi
role
b
hcv
life
cycl
year
complex
function
lipid
clear
yet
shown
lipid
local
chang
membran
curvatur
lipid
enrich
membran
could
therefor
gener
highcurvatur
membran
pocket
protect
viral
protein
rna
host
defens
hand
lipid
may
provid
bind
site
concentr
viralhost
protein
membran
web
effici
viral
rna
synthesi
sever
bind
host
protein
cert
previous
identifi
host
factor
hcv
replic
altern
hcv
protein
may
also
abl
bind
lipid
although
hcv
protein
contain
canon
pipbind
motif
number
nonpredict
pipbind
protein
identifi
experiment
rnadepend
rna
polymeras
polioviru
studi
therefor
requir
determin
import
accumul
hcv
replic
complex
anoth
recent
hypothesi
influenc
modul
hcv
phosphoryl
support
synthesi
therebi
stimul
rna
replic
fig
modifi
phosphoryl
give
rise
basal
hyperphosphoryl
variant
believ
involv
regul
viral
replic
cycl
favor
rna
replic
assembl
respect
loss
interact
rna
replic
correl
increas
level
suggest
might
involv
regul
phosphoryl
overexpress
knockdown
result
rel
increas
decreas
portion
respect
remain
elucid
whether
phosphoryl
directli
indirectli
modul
involv
hcv
replic
studi
indic
play
role
step
hcv
infect
b
suggest
essenti
intern
step
hcv
depend
seem
influenc
particular
genotyp
hcv
pseudoparticl
hcvpp
although
precursor
pi
p
recruit
protein
requir
clathrinmedi
endocytosi
cme
inhibit
hcv
entri
observ
b
knockdown
seem
unrel
disrupt
cme
inde
endocytosi
label
transferrin
infer
silenc
b
affect
surfac
express
srbi
receptor
suggest
transport
membran
protein
cell
surfac
disrupt
studi
show
howev
effect
hcvpp
entri
huh
cell
gene
silenc
pool
individu
sirna
combin
approach
rnai
analysi
host
factor
live
cell
imag
hcv
core
traffick
recent
identifi
host
factor
requir
infecti
hcv
releas
cotraff
hcv
core
also
compon
secretori
pathway
identifi
strategi
other
knockdown
sirna
result
inhibit
hcv
infect
quantifi
effect
core
movement
presenc
role
exit
golgi
core
traffick
assess
treatment
mm
concentr
specif
inhibit
reduc
averag
veloc
motil
core
puncta
furthermor
silenc
decreas
local
core
vesicular
associ
membran
protein
cofactor
releas
infecti
hcv
particl
also
identifi
rnai
screen
data
suggest
involv
differ
step
viral
life
cycl
famili
picornavirida
group
nonenvelop
singlestrand
positivesens
rna
virus
picornavirus
includ
mani
import
human
pathogen
well
anim
picornavirus
reli
host
intracellular
membran
replic
replic
membran
appear
origin
er
case
hcv
cellular
factor
believ
essenti
membran
reorgan
mani
studi
demonstr
involv
adpribosyl
factor
golgispecif
brefeldin
resist
factor
replic
enterovirus
recent
host
factor
also
shown
requir
viral
rna
replic
multipl
picornavirus
fig
hsu
et
al
demonstr
eleg
studi
enterovirus
polioviru
coxsackieviru
remodel
host
secretori
pathway
gener
replic
organel
fig
previous
mention
known
host
factor
enterovir
replic
uninfect
mammalian
cell
host
protein
local
er
golgi
apparatu
major
effector
site
includ
immunofluoresc
experi
reveal
remain
coloc
enterovir
infect
contrast
effector
coloc
depend
local
activ
furthermor
shown
associ
enterovir
protein
express
alon
enhanc
membran
recruit
contrast
hcv
shown
interact
direct
interact
observ
howev
shown
bind
directli
also
observ
hcv
enteroviru
infect
stimul
synthesi
lipid
level
replic
complex
substanti
fraction
lipid
product
activ
interestingli
proteinlipid
overlay
studi
suggest
enterovir
pol
rna
polymeras
preferenti
bind
lipid
base
find
model
propos
reorgan
secretori
pathway
enteroviru
infect
membranebound
protein
bind
modul
enhanc
recruit
membran
synthesi
lipid
catalyz
result
membran
microenviron
lipidrich
microenviron
turn
enhanc
recruit
rnadepend
rna
polymeras
pol
pol
part
replic
complex
initi
rna
synthesi
membran
recent
shown
aichi
viru
anoth
picornaviru
belong
genu
kobuvirus
also
requir
rna
replic
fig
intriguingli
aichi
viru
adopt
differ
strategi
recruit
viral
replic
site
use
enterovirus
recruit
aichi
viru
replic
complex
depend
reli
interact
golgi
protein
acylcoenzym
bind
domain
protein
protein
involv
mainten
golgi
apparatu
structur
local
golgi
occur
interact
giantin
aichi
viru
nonstructur
protein
shown
interact
viral
proteinbind
domain
overlap
bind
domain
giantin
addit
observ
interact
direct
interact
viral
protein
observ
interestingli
studi
demonstr
aichi
viru
replic
contrast
enteroviru
replic
insensit
brefeldin
bfa
bfa
inactiv
therefor
inhibit
bind
viral
protein
differ
sensit
bfa
aichi
viru
enterovirus
thu
corrobor
observ
virus
adopt
differ
recruit
strategi
knockdown
sirna
inhibit
viral
rna
replic
respect
shown
coloc
aichi
viru
nonstructur
protein
level
replic
complex
cell
case
enterovirus
hcv
lipid
shown
accumul
aichi
viru
replic
site
base
result
current
hypothesi
aichi
viru
membran
protein
compet
giantin
bind
golgi
form
viral
protein
complex
doubl
function
complex
one
hand
abl
recruit
viral
protein
result
increas
concentr
viral
protein
golgi
hand
effici
recruit
replic
site
result
lipidenrich
environ
whether
lipid
abl
bind
rna
polymeras
aichi
viru
remain
elucid
strategi
picornavirus
recruit
confirm
grening
et
al
use
mass
spectrometrybas
proteom
approach
fig
demonstr
protein
multipl
picornavirus
includ
aichi
viru
bovin
kobuviru
cvb
polioviru
associ
picornavirus
appear
associ
name
cardiovirus
surprisingli
despit
insensit
bfa
knockdown
abolish
aichi
viral
replic
howev
possibl
replic
inhibit
due
loss
indirectli
caus
loss
knockdown
inhibit
aichi
viru
replic
also
polio
viru
replic
sinc
far
two
differ
recruit
strategi
observ
picornavirida
famili
interest
explor
whether
picornavirus
requir
replic
recruit
replic
complex
first
report
alter
activ
viru
infect
publish
elev
phosphatidylinositol
kinas
activ
observ
rou
sarcoma
viru
alpharetroviru
transform
cell
elev
indirectli
enhanc
transform
oncoprotein
viru
similarli
activ
increas
human
b
cell
infect
epsteinbarr
viru
dna
herpesviru
mechan
observ
increas
remain
unclear
also
hijack
phosphoinositid
signal
system
interestingli
pi
p
seem
major
phosphoinositid
involv
pi
p
play
critic
role
target
gag
plasma
membran
deplet
pi
p
compromis
viru
assembl
lead
accumul
gag
membran
late
endosom
multipl
vesicular
bodi
furthermor
found
larg
enrich
virion
recent
studi
demonstr
pi
p
bind
directli
matrix
domain
gag
protein
therebi
regul
gag
local
assembl
plasma
membran
contrast
relat
phosphoinositid
like
pi
p
bind
matrix
domain
substanti
affin
howev
monoclon
antibodi
specif
inhibit
infect
two
primari
isol
neutral
assay
antibodi
directli
bind
target
cell
prior
bind
shown
fluorescenceactiv
cell
sorter
analysi
notwithstand
hypothes
effect
possibl
due
reaction
antibodi
pi
p
viral
assembl
bud
contrast
rou
sarcoma
viru
gag
specif
requir
pi
p
plasma
membran
associ
deplet
pi
p
affect
releas
viruslik
particl
membran
local
gag
moreov
liposom
flotat
experi
demonstr
rou
sarcoma
viru
gag
requir
acid
lipid
bind
show
specif
pi
p
replic
west
nile
viru
wnv
genu
flaviviru
within
famili
flavivirida
also
hcv
belong
independ
agreement
observ
silenc
effect
dengu
viru
anoth
flaviviru
replic
wnv
infect
alter
local
lipid
coloc
observ
dsrna
furthermor
reduct
wnv
rna
replic
observ
upon
treatment
instead
fatti
acid
seem
requir
viral
replic
sinc
inhibit
fatti
acid
synthas
fasn
reduc
wnv
product
fasn
shown
local
close
wnv
replic
complex
infect
cell
shown
involv
entri
sar
coronaviru
sar
cov
silenc
strongli
inhibit
sar
cov
spikemedi
entri
transient
transfect
pi
phosphatas
convert
lipid
back
pi
reduc
sar
cov
entri
indic
lipid
essenti
viral
entri
furthermor
shown
requir
viru
bind
intern
play
role
viru
fusion
late
endosom
promis
target
therapeut
intervent
involv
differ
step
life
cycl
sever
virus
lipid
kinas
repres
potenti
promis
target
develop
inhibitor
viral
replic
target
host
factor
instead
viral
protein
attract
yet
controversi
strategi
antivir
intervent
one
hand
barrier
resist
hosttarget
antivir
hta
appar
higher
hand
inhibit
host
factor
may
higher
chanc
result
toxicityadvers
effect
moreov
polymorph
host
factor
variant
express
level
patient
may
complic
factor
feasibl
antivir
strategi
like
depend
host
factor
target
viru
cell
depend
function
extens
mous
genet
studi
perform
boehring
ingelheim
estim
potenti
effect
inhibit
vivo
thu
assess
safeti
inhibitor
knockdown
result
lethal
phenotyp
within
day
mice
next
condit
knockin
line
gener
wellfold
enzymat
inact
kinas
induc
induct
anim
homozyg
knockin
gene
display
lethal
phenotyp
similar
less
dramat
observ
induc
knockdown
model
heterozyg
anim
model
display
less
sever
phenotyp
followup
result
need
defin
potenti
role
target
therapeut
intervent
anoth
major
challeng
develop
inhibitor
achiev
select
inhibit
even
isoform
b
commonli
use
specif
inhibitor
phenylthiazol
fig
origin
develop
inhibitor
class
vitro
kinas
assay
found
potent
ineffect
type
ii
tabl
howev
higher
concentr
also
seem
inhibit
shown
inhibit
vitro
picornaviru
hcv
replic
anoth
inhibitor
enviroxim
isopropylsulfonyl
phenyl
keton
oxim
fig
enviroxim
sinc
long
known
inhibitor
vitro
replic
rhinovirus
enterovirus
tabl
recent
demonstr
enviroxim
inhibit
hcv
subgenom
replicon
replic
picornavirus
resist
enviroxim
carri
mutat
protein
picornaviru
protein
membran
associ
protein
involv
format
membran
web
direct
interact
enviroxim
protein
report
clinic
trial
natur
experiment
induc
rhinoviru
infect
produc
disappoint
result
drug
develop
decad
clear
mechan
enviroxim
inhibit
replic
picornavirus
recent
arita
colleagu
demonstr
enviroxim
inhibit
rna
replic
picornavirus
inhibit
order
identifi
highli
specif
inhibitor
novarti
carri
small
molecul
high
throughput
screen
sever
differ
chemic
molecul
class
identifi
select
inhibitor
interestingli
molecul
also
strongli
inhibit
hcv
subgenom
replicon
genotyp
viru
genotyp
vitro
tabl
high
barrier
resist
suggest
observ
low
level
resist
follow
resist
select
repres
molecul
compound
five
week
although
cellular
function
insulin
secret
regul
ion
channel
seem
perturb
unexpect
antiprolif
effect
lymphocyt
imped
develop
inhibitor
antivir
agent
hcv
anoth
new
class
inhibitor
class
quinazolin
fig
first
identifi
inhibitor
vitro
hcv
replic
target
class
molecul
thought
viral
protein
howev
molecul
prototyp
class
recent
shown
inhibit
purifi
lesser
extent
ic
mm
vs
mm
tabl
treatment
huh
cell
result
gradual
decreas
level
plasma
membran
indic
agent
inhibit
intact
cell
hand
influenc
level
golgi
membran
suggest
inhibit
cell
express
hcv
protein
treatment
induc
abnorm
larg
cluster
therefor
propos
antivir
effect
quinazolin
result
inhibit
consequ
deplet
lipid
note
also
shown
inhibit
class
ic
mm
lesser
extent
ic
mm
elabor
result
sirna
screen
identifi
host
factor
hcv
boehring
ingelheim
perform
enzymat
screen
search
specif
inhibitor
cell
cultur
studi
inhibitor
demonstr
lipid
kinas
activ
rather
proteinprotein
interact
alon
essenti
hcv
rna
replic
fig
note
inhibitor
exhibit
also
activ
certain
lipid
kinas
specifi
hcv
resist
class
inhibitor
map
ctermin
end
ntermin
domain
mous
genet
studi
mention
work
antihcv
drug
target
termin
sever
virus
abl
hijack
host
cell
differ
way
virus
produc
either
protein
recruit
activ
replic
complex
effector
protein
use
membran
anchor
role
picornaviru
replic
rel
well
describ
character
role
hcv
replic
identif
hcvhost
factor
provid
futur
challeng
point
lohmann
colleagu
exclud
increas
level
hcvinfect
cell
coincident
relev
hcv
replic
sinc
tent
role
phosphoryl
suggest
fig
could
well
simultan
recruit
protein
kinas
cf
supra
phosphoryl
protein
compet
protein
kinas
could
result
modul
phosphoryl
concomit
assemblydissoci
hcv
replicas
complex
howev
protein
kinas
known
phosphoryl
neg
regul
hcv
viru
particl
egress
effect
mediat
osb
cert
latter
protein
mention
essenti
de
novo
sphingomyelin
synthesi
shown
requir
hcv
replic
particular
virionassoci
sphingomyelin
essenti
infect
hcv
virion
recent
shown
depend
genotyp
sphingomyelin
activ
hcv
rnadepend
rna
polymeras
thu
hcv
might
exploit
curb
sphingomyelin
metabol
benefit
suggest
lindenbach
hcv
creat
unctuou
home
replic
home
might
well
resembl
uniqu
membran
cluster
associ
variou
organel
multivesicular
bodi
mitochondria
er
mammalian
nervou
system
manipul
pi
metabol
pi
distribut
hcv
might
limit
find
show
essenti
role
suggest
even
extens
manipul
system
hcv
virus
relat
hcv
flavivirus
denv
wnv
depend
replic
virus
retrovirus
clearli
link
need
pi
p
target
gag
plasma
membran
also
ebv
seem
requir
increas
activ
surprisingli
requir
sarscov
entri
interest
entir
unrel
virus
hcv
picornavirus
ebv
retrovirus
coronavirus
exploit
appar
larg
unrel
mechan
question
remain
whether
good
target
inhibit
viral
replic
patient
knockdown
mice
suggest
least
enzym
critic
may
thu
liabil
antivir
target
present
isoform
target
specif
known
inhibitor
far
optim
interest
studi
whether
inhibitor
highli
specif
one
isoform
develop
whether
suffici
therapeut
window
furthermor
altern
target
strategi
could
envis
interfer
enzymat
activ
possibl
result
less
advers
side
effect
inde
interfac
interact
viral
factor
picornaviru
may
potenti
drugabl
